Exact Mass: 427.2031288
Exact Mass Matches: 427.2031288
Found 489 metabolites which its exact mass value is equals to given mass value 427.2031288,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Moricizine
C22H25N3O4S (427.15656900000005)
Moricizine is only found in individuals that have used or taken this drug. It is an antiarrhythmia agent used primarily for ventricular rhythm disturbances. [PubChem]Moricizine works by inhibiting the rapid inward sodium current across myocardial cell membranes. D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Ranolazine
C24H33N3O4 (427.2470938000001)
Ranolazine is only found in individuals that have used or taken this drug. It is an antianginal medication. On January 31, 2006, ranolazine was approved for use in the United States by the FDA for the treatment of chronic angina. [Wikipedia]The mechanism of action of ranolazine is unknown. It does not increase the rate-pressure product, a measure of myocardial work, at maximal exercise. In vitro studies suggest that ranolazine is a P-gp inhibitor. Ranolazine is believed to have its effects via altering the trans-cellular late sodium current. It is by altering the intracellular sodium level that ranolazine affects the sodium-dependent calcium channels during myocardial ischemia. Thus, ranolazine indirectly prevents the calcium overload that causes cardiac ischemia. C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers C - Cardiovascular system > C01 - Cardiac therapy D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Dihydroxyacidissiminol
C25H33NO5 (427.23586080000007)
Dihydroxyacidissiminol is found in beverages. Dihydroxyacidissiminol is an alkaloid from fruits of Limonia acidissima (wood apple). Alkaloid from fruits of Limonia acidissima (wood apple). Dihydroxyacidissiminol is found in beverages and fruits.
6-Hydroxyfluvastatin
C24H26FNO5 (427.17949180000005)
6-Hydroxyfluvastatin is only found in individuals that have used or taken Fluvastatin. 6-Hydroxyfluvastatin is a metabolite of Fluvastatin. 6-hydroxyfluvastatin belongs to the family of Indoles. These are compounds containing an indole moiety, which consists of pyrrole ring fused to benzene to form 2,3-benzopyrrole.
5-Hydroxyfluvastatin
C24H26FNO5 (427.17949180000005)
5-Hydroxyfluvastatin is only found in individuals that have used or taken Fluvastatin. 5-Hydroxyfluvastatin is a metabolite of Fluvastatin. 5-hydroxyfluvastatin belongs to the family of Indoles. These are compounds containing an indole moiety, which consists of pyrrole ring fused to benzene to form 2,3-benzopyrrole.
(1-(2-(Methylsulfonamido)ethyl)piperidin-4-yl)methyl 5-fluoro-2-methoxy-1H-indole-3-carboxylate
C19H26FN3O5S (427.1577118000001)
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists
Dixyrazine
C24H33N3O2S (427.22933580000006)
N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D005765 - Gastrointestinal Agents > D000932 - Antiemetics
Mozavaptan
C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2180 - Vasopressin Antagonist D045283 - Natriuretic Agents > D065092 - Antidiuretic Hormone Receptor Antagonists D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents
Tropantiol
C21H34ClN3S2 (427.18825540000006)
(2R,3R,4S,5S,6R)-2-(3-(4-Cyclopropylbenzyl)-4-fluoro-1H-indol-1-yl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
C24H26FNO5 (427.17949180000005)
Valyl-prolyl-glycyl-valyl-glycine
C19H33N5O6 (427.24307180000005)
Lasiocarpine N-oxide
C21H33NO8 (427.22060580000004)
CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2306
Arachidonoyl ethanolamide phosphate
C22H38NO5P (427.24874680000005)
Dixyrazine
C24H33N3O2S (427.22933580000006)
N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D005765 - Gastrointestinal Agents > D000932 - Antiemetics CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu); Flow Injection CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu) HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu); CONFIDENCE Reference Standard (Level 1)
(1aS,2aS,5S,5aS,6S,6aR)-5-benzylhexahydro-2a-hydroxy-2-[(1E,4S,6S)-6-hydroxy-4-methyl-5-oxohept-1-enyl]-6,6a-dimethyl-3H-oxireno[f]isoindol-3-one|cytochalasin Z20
C25H33NO5 (427.23586080000007)
(7R)-8t-acetoxy-6,7-dimethoxy-2-methyl-6,8,3,4-tetrahydro-2H-(7rN)-spiro[indeno[4,5-d][1,3]dioxole-7,1-isoquinolin]-6t-ol|Raddeanidin|Raddeanidine
2-[[2-[(2-amino-3-phenyl-propanoyl)amino]-3-methyl-butanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid
C23H29N3O5 (427.21071040000004)
Lasiocarpine N-oxide
C21H33NO8 (427.22060580000004)
Lasiocarpine N-oxide is a natural product found in Heliotropium hirsutissimum and Heliotropium ellipticum with data available.
8-benzyl-9,10-dimethoxy-5,8-dihydro-6H-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinoline
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.995
RANOLAZINE
C24H33N3O4 (427.2470938000001)
C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers C - Cardiovascular system > C01 - Cardiac therapy D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
(2R,2R,4aS,6R,8aS)-4-hydroxy-2,5,5,8a-tetramethyl-6-oxo-3,3,4,4a,5,6,6,7,7,8,8,8a-dodecahydro-2H-spiro[furo[2,3-e]isoindole-2,1-naphthalen]-6-yl acetate
C25H33NO5 (427.23586080000007)
Ala His Asn Ser
Ala His Ser Asn
Ala Ile Pro Gln
C19H33N5O6 (427.24307180000005)
Ala Ile Gln Pro
C19H33N5O6 (427.24307180000005)
Ala Leu Pro Gln
C19H33N5O6 (427.24307180000005)
Ala Leu Gln Pro
C19H33N5O6 (427.24307180000005)
Ala Asn His Ser
Ala Asn Ser His
Ala Pro Ile Gln
C19H33N5O6 (427.24307180000005)
Ala Pro Leu Gln
C19H33N5O6 (427.24307180000005)
Ala Pro Gln Ile
C19H33N5O6 (427.24307180000005)
Ala Pro Gln Leu
C19H33N5O6 (427.24307180000005)
Ala Gln Ile Pro
C19H33N5O6 (427.24307180000005)
Ala Gln Leu Pro
C19H33N5O6 (427.24307180000005)
Ala Gln Pro Ile
C19H33N5O6 (427.24307180000005)
Ala Gln Pro Leu
C19H33N5O6 (427.24307180000005)
Ala Ser His Asn
Ala Ser Asn His
Gly His Lys Ser
Gly His Asn Thr
Gly His Gln Ser
Gly His Ser Lys
Gly His Ser Gln
Gly His Thr Asn
Gly Lys His Ser
Gly Lys Ser His
Gly Asn His Thr
Gly Asn Thr His
Gly Gln His Ser
Gly Gln Ser His
Gly Ser His Lys
Gly Ser His Gln
Gly Ser Lys His
Gly Ser Gln His
Gly Thr His Asn
Gly Thr Asn His
His Ala Asn Ser
His Ala Ser Asn
His Gly Lys Ser
His Gly Asn Thr
His Gly Gln Ser
His Gly Ser Lys
His Gly Ser Gln
His Gly Thr Asn
His Lys Gly Ser
His Lys Ser Gly
His Asn Ala Ser
His Asn Gly Thr
His Asn Ser Ala
His Asn Thr Gly
His Gln Gly Ser
His Gln Ser Gly
His Ser Ala Asn
His Ser Gly Lys
His Ser Gly Gln
His Ser Lys Gly
His Ser Asn Ala
His Ser Gln Gly
His Thr Gly Asn
His Thr Asn Gly
Ile Ala Pro Gln
C19H33N5O6 (427.24307180000005)
Ile Ala Gln Pro
C19H33N5O6 (427.24307180000005)
Ile Pro Ala Gln
C19H33N5O6 (427.24307180000005)
Ile Pro Gln Ala
C19H33N5O6 (427.24307180000005)
Ile Gln Ala Pro
C19H33N5O6 (427.24307180000005)
Ile Gln Pro Ala
C19H33N5O6 (427.24307180000005)
Lys Gly His Ser
Lys Gly Ser His
Lys His Gly Ser
Lys His Ser Gly
Lys Pro Pro Ser
C19H33N5O6 (427.24307180000005)
Lys Pro Ser Pro
C19H33N5O6 (427.24307180000005)
Lys Ser Gly His
Lys Ser His Gly
Lys Ser Pro Pro
C19H33N5O6 (427.24307180000005)
Leu Ala Pro Gln
C19H33N5O6 (427.24307180000005)
Leu Ala Gln Pro
C19H33N5O6 (427.24307180000005)
Leu Pro Ala Gln
C19H33N5O6 (427.24307180000005)
Leu Pro Gln Ala
C19H33N5O6 (427.24307180000005)
Leu Gln Ala Pro
C19H33N5O6 (427.24307180000005)
Leu Gln Pro Ala
C19H33N5O6 (427.24307180000005)
Asn Ala His Ser
Asn Ala Ser His
Asn Gly His Thr
Asn Gly Thr His
Asn His Ala Ser
Asn His Gly Thr
Asn His Ser Ala
Asn His Thr Gly
Asn Pro Pro Thr
Asn Pro Thr Pro
Asn Pro Val Val
C19H33N5O6 (427.24307180000005)
Asn Ser Ala His
Asn Ser His Ala
Asn Thr Gly His
Asn Thr His Gly
Asn Thr Pro Pro
Asn Val Pro Val
C19H33N5O6 (427.24307180000005)
Asn Val Val Pro
C19H33N5O6 (427.24307180000005)
Pro Ala Ile Gln
C19H33N5O6 (427.24307180000005)
Pro Ala Leu Gln
C19H33N5O6 (427.24307180000005)
Pro Ala Gln Ile
C19H33N5O6 (427.24307180000005)
Pro Ala Gln Leu
C19H33N5O6 (427.24307180000005)
Pro Ile Ala Gln
C19H33N5O6 (427.24307180000005)
Pro Ile Gln Ala
C19H33N5O6 (427.24307180000005)
Pro Lys Pro Ser
C19H33N5O6 (427.24307180000005)
Pro Lys Ser Pro
C19H33N5O6 (427.24307180000005)
Pro Leu Ala Gln
C19H33N5O6 (427.24307180000005)
Pro Leu Gln Ala
C19H33N5O6 (427.24307180000005)
Pro Asn Pro Thr
Pro Asn Thr Pro
Pro Asn Val Val
C19H33N5O6 (427.24307180000005)
Pro Pro Lys Ser
C19H33N5O6 (427.24307180000005)
Pro Pro Asn Thr
Pro Pro Gln Ser
Pro Pro Ser Lys
C19H33N5O6 (427.24307180000005)
Pro Pro Ser Gln
Pro Pro Thr Asn
Pro Gln Ala Ile
C19H33N5O6 (427.24307180000005)
Pro Gln Ala Leu
C19H33N5O6 (427.24307180000005)
Pro Gln Ile Ala
C19H33N5O6 (427.24307180000005)
Pro Gln Leu Ala
C19H33N5O6 (427.24307180000005)
Pro Gln Pro Ser
Pro Gln Ser Pro
Pro Ser Lys Pro
C19H33N5O6 (427.24307180000005)
Pro Ser Pro Lys
C19H33N5O6 (427.24307180000005)
Pro Ser Pro Gln
Pro Ser Gln Pro
Pro Thr Asn Pro
Pro Thr Pro Asn
Pro Val Asn Val
C19H33N5O6 (427.24307180000005)
Pro Val Val Asn
C19H33N5O6 (427.24307180000005)
Gln Ala Ile Pro
C19H33N5O6 (427.24307180000005)
Gln Ala Leu Pro
C19H33N5O6 (427.24307180000005)
Gln Ala Pro Ile
C19H33N5O6 (427.24307180000005)
Gln Ala Pro Leu
C19H33N5O6 (427.24307180000005)
Gln Gly His Ser
Gln Gly Ser His
Gln His Gly Ser
Gln His Ser Gly
Gln Ile Ala Pro
C19H33N5O6 (427.24307180000005)
Gln Ile Pro Ala
C19H33N5O6 (427.24307180000005)
Gln Leu Ala Pro
C19H33N5O6 (427.24307180000005)
Gln Leu Pro Ala
C19H33N5O6 (427.24307180000005)
Gln Pro Ala Ile
C19H33N5O6 (427.24307180000005)
Gln Pro Ala Leu
C19H33N5O6 (427.24307180000005)
Gln Pro Ile Ala
C19H33N5O6 (427.24307180000005)
Gln Pro Leu Ala
C19H33N5O6 (427.24307180000005)
Gln Pro Pro Ser
Gln Pro Ser Pro
Gln Ser Gly His
Gln Ser His Gly
Gln Ser Pro Pro
Ser Ala His Asn
Ser Ala Asn His
Ser Gly His Lys
Ser Gly His Gln
Ser Gly Lys His
Ser Gly Gln His
Ser His Ala Asn
Ser His Gly Lys
Ser His Gly Gln
Ser His Lys Gly
Ser His Asn Ala
Ser His Gln Gly
Ser Lys Gly His
Ser Lys His Gly
Ser Lys Pro Pro
C19H33N5O6 (427.24307180000005)
Ser Asn Ala His
Ser Asn His Ala
Ser Pro Lys Pro
C19H33N5O6 (427.24307180000005)
Ser Pro Pro Lys
C19H33N5O6 (427.24307180000005)
Ser Pro Pro Gln
Ser Pro Gln Pro
Ser Gln Gly His
Ser Gln His Gly
Ser Gln Pro Pro
Thr Gly His Asn
Thr Gly Asn His
Thr His Gly Asn
Thr His Asn Gly
Thr Asn Gly His
Thr Asn His Gly
Thr Asn Pro Pro
Thr Pro Asn Pro
Thr Pro Pro Asn
Val Asn Pro Val
C19H33N5O6 (427.24307180000005)
Val Asn Val Pro
C19H33N5O6 (427.24307180000005)
Val Pro Asn Val
C19H33N5O6 (427.24307180000005)
Val Pro Val Asn
C19H33N5O6 (427.24307180000005)
Val Val Asn Pro
C19H33N5O6 (427.24307180000005)
Val Val Pro Asn
C19H33N5O6 (427.24307180000005)
Anandamide 0-phosphate
C22H38NO5P (427.24874680000005)
20-hydroxy N-Arachidonoyl Taurine
C22H37NO5S (427.23923120000006)
Dihydroxyacidissiminol
C25H33NO5 (427.23586080000007)
Anandamide O-phosphate
C22H38NO5P (427.24874680000005)
7-(2,2-Diphenylethenyl)-1,2,3,3A,4,8B-hexahydro-4-(4-methylphenyl)cyclopent[B]indole
Pentaerythritol tris-[3-(1-aziridinyl)-propionate]
C20H33N3O7 (427.23183880000005)
2-[[(3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol (2R,3R)-2,3-dihydroxybutanedioate
C16H29NO12 (427.16896740000004)
(-)-n-dodecyl-n-methylephedrinium bromide
C23H42BrNO (427.24495820000004)
21-Amino-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione hydrochloride
C22H31ClFNO4 (427.19255280000004)
Flavoxate hydrochloride
C24H26ClNO4 (427.1550266000001)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D000089162 - Genitourinary Agents > D064804 - Urological Agents Flavoxate hydrochloride is a potent and competitive phosphodiesterase (PDE) inhibitor. Flavoxate hydrochloride is an antispasmodic agent and muscarinic mAChR antagonist. Flavoxate hydrochloride shows moderate calcium antagonistic activity and local anesthetic effect. Flavoxate hydrochloride can be used for the research of overactive bladder (OAB) and lower urinary tract infections[1].
(S,E)-3-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-6-PHENYLHEX-5-ENOIC ACID
4-(2-HYDROXYETHYL)-3-METHYL-5-OXO-2,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXIMIDAMIDE
3-[3-tert-butyl-5-(5-chlorobenzotriazol-2-yl)-4-hydroxyphenyl]propyl 2-methylprop-2-enoate
C23H26ClN3O3 (427.1662596000001)
3-Indoxyl Phosphate, Di-p-Toluidinium Salt
C22H26N3O4P (427.1660846000001)
2-[2-[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3.2.1]octan-4-yl]methyl-(2-sulfanylethyl)amino]ethylamino]ethanethiol
C21H34ClN3S2 (427.18825540000006)
Trospium Chloride
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent D000089162 - Genitourinary Agents > D064804 - Urological Agents Trospium chloride is an orally active, specific and competitive antagonist of muscarinic cholinergic receptors (mAChRs), with antimuscarinic activity. Trospium chloride binds to muscarinic receptors M1, M2 and M3 with high affinity, but not nicotinic, cholinergic receptors[1][2].
Panomifene
C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist
Oxyphenonium bromide
C21H34BrNO3 (427.1721914000001)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent Oxyphenonium bromide is an antiacetylcholine compound. Oxyphenonium bromide is an antagonist of mAChR. Oxyphenonium bromide protects against the bronchial obstructive effects[1][2][3].
2(1H)-Pyrimidinone, 4-amino-1-[(2S)-2-hydroxy-3-(triphenylmethoxy)propyl]-
4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinecarboxylic acid 2-(2-hydroxyethoxy)ethyl ester
C22H25N3O4S (427.15656900000005)
N,N-Bis[2-(7-methoxy-1-naphthalenyl)ethyl]acetamide
2-Azido-2-deoxy-3,4-bis-O-(phenylmethyl)-D-galactose 6-acetate
Benzoic acid, 4-[[(5-ethoxy-5-oxopentyl)[2-(2-Methoxyphenyl)ethyl]aMino]Methyl]-, Methyl ester
C25H33NO5 (427.23586080000007)
(11BETA,16BETA)-PREGNA-1,4-DIENE-3,20-DIONE,21-AMINO-9-FLUORO-11,17-DIHYDROXY-16-METHYL-,HYDROCHLORIDE
C22H31ClFNO4 (427.19255280000004)
(5-{3-[5-(Piperidin-1-Ylmethyl)-1h-Indol-2-Yl]-1h-Indazol-6-Yl}-2h-1,2,3-Triazol-4-Yl)methanol
Ivaltinostat
C24H33N3O4 (427.2470938000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
3-(1,3-Benzodioxol-5-yl)-3-(2-hydroxy-4,6-dimethoxyphenyl)-1-(4-methyl-1-piperidinyl)-1-propanone
C24H29NO6 (427.19947740000003)
7-(4-Benzylpiperazin-1-yl)-3-(2-methoxyphenyl)-2,5-dimethylpyrazolo[1,5-a]pyrimidine
(3r)-3-Cyclopentyl-6-Methyl-7-[(4-Methylpiperazin-1-Yl)sulfonyl]-3,4-Dihydro-2h-1,2-Benzothiazine 1,1-Dioxide
C19H29N3O4S2 (427.15993940000004)
N-[4-[[4-(cyclopropylmethyl)piperazin-1-yl]methyl]phenyl]-4-propylbenzenesulfonamide
C24H33N3O2S (427.22933580000006)
Tropantiol
C21H34ClN3S2 (427.18825540000006)
[3-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methylsulfanyl]-8-azaniumyloctyl]azanium
C18H33N7O3S+2 (427.23654680000004)
methyl (1S,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-10-hydroxy-8-methyl-8-aza-16-azoniapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate
N-(2-carbamoylphenyl)-2-(2,5-dimethoxyphenyl)quinoline-4-carboxamide
C25H21N3O4 (427.15319860000005)
3-(1,3-Benzodioxol-5-yl)-3-(2-hydroxy-4,6-dimethoxyphenyl)-1-(3-methyl-1-piperidinyl)-1-propanone
C24H29NO6 (427.19947740000003)
Magnocurarine trifluoroacetate, rac-
C21H24F3NO5 (427.16064900000003)
A natural product found in Gnetum montanum.
N,N-dipropyl-2-[4-methoxy-3-(2-phenylethoxyl)phenyl]ethylamine hydrochloride
Phe-Phe-Asp
A tripeptide composed of two L-phenylalanine units and L-aspartic acid joined by peptide linkages.
1,4-Dimethyl-6-[[4-(phenylmethyl)-1-piperidinyl]sulfonyl]quinoxaline-2,3-dione
C22H25N3O4S (427.15656900000005)
4-methyl-N-[3-[1-(phenylmethyl)-4-piperidinyl]-2,4-dihydro-1H-1,3,5-triazin-6-yl]benzenesulfonamide
C22H29N5O2S (427.20418540000003)
1-[4-[2-(4-Methoxyphenyl)-5-phenyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]ethanone
(5E)-1-cyclohexyl-5-[1-[[2-(3-pyridyl)piperidino]amino]ethylidene]-2-thioxo-hexahydropyrimidine-4,6-quinone
C22H29N5O2S (427.20418540000003)
1-Azelaoyl-sn-glycero-3-phosphocholine
A 1-O-acyl-sn-glycero-3-phosphocholine obtained by formal condensation of one of the carboxy groups of azelaic acid with the 1-hydroxy group of sn-glycero-3-phosphocholine.
2-Azelaoyl-sn-glycero-3-phosphocholine
A 2-acyl-sn-glycero-3-phosphocholine obtained by formal condensation of one of the carboxy groups of azelaic acid with the 1-hydroxy group of sn-glycero-3-phosphocholine.
1-(7-Methyloctyl)-3-[4-(4-morpholinylsulfonyl)phenyl]thiourea
N-[[4-(2-ethoxyphenyl)-1-piperazinyl]-sulfanylidenemethyl]-1-adamantanecarboxamide
C24H33N3O2S (427.22933580000006)
1-[(2-chlorophenyl)methyl]-N-[3-(N-ethyl-3-methylanilino)propyl]-5-oxo-2-pyrrolidinecarboxamide
N-(2-furanylmethyl)-N-[(7-methyl-4-tetrazolo[1,5-a]quinolinyl)methyl]-2-phenoxyacetamide
C24H21N5O3 (427.16443160000006)
N,N-dimethyl-4-[[4-(5-methyl-1-benzotriazolyl)-1-piperidinyl]sulfonyl]benzamide
C21H25N5O3S (427.16780200000005)
4-[(4-Cyclohexyl-1-piperazinyl)-oxomethyl]-2-ethyl-6,7-dimethoxy-1-isoquinolinone
C24H33N3O4 (427.2470938000001)
13-(3-Ethoxypropyl)-14-methyl-17-(4-methylphenyl)-2,9,13,15,17-pentazatetracyclo[8.7.0.03,8.011,16]heptadeca-1,3,5,7,9,11(16),14-heptaen-12-one
(6R,7R,8R)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-4-[oxo(pyridin-4-yl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8R)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-4-[oxo(pyridin-4-yl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
N-(1-cyclohexyl-3-hydroxy-3,4-diphenylbutyl)benzamide
C29H33NO2 (427.25111580000004)
3-fluoro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide
C19H26FN3O5S (427.1577118000001)
3-fluoro-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide
C19H26FN3O5S (427.1577118000001)
N-[2-[1-[2-(2,5-difluorophenoxy)ethyl]-2-benzimidazolyl]ethyl]cyclohexanecarboxamide
C24H27F2N3O2 (427.20712260000005)
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]pyrazine-2-carboxamide
C22H29N5O4 (427.22194340000004)
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]pyrazine-2-carboxamide
C22H29N5O4 (427.22194340000004)
N-[3-(dimethylamino)propyl]-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]oxan-2-yl]acetamide
C20H33N3O5S (427.2140808000001)
N-[3-(dimethylamino)propyl]-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]acetamide
C20H33N3O5S (427.2140808000001)
3-fluoro-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide
C19H26FN3O5S (427.1577118000001)
3-fluoro-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide
C19H26FN3O5S (427.1577118000001)
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]pyrazine-2-carboxamide
C22H29N5O4 (427.22194340000004)
N-[3-(dimethylamino)propyl]-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]oxan-2-yl]acetamide
C20H33N3O5S (427.2140808000001)
3-fluoro-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide
C19H26FN3O5S (427.1577118000001)
(2R,3R,4S)-2-cyano-N-(2-fluorophenyl)-4-(hydroxymethyl)-3-[4-[(E)-2-phenylethenyl]phenyl]azetidine-1-carboxamide
(2R,3R,3aS,9bS)-N-(cyclohexylmethyl)-1-(2-cyclopropyl-1-oxoethyl)-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C24H33N3O4 (427.2470938000001)
N-[[(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide
C20H33N3O5S (427.2140808000001)
N-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide
C20H33N3O5S (427.2140808000001)
N-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C20H33N3O5S (427.2140808000001)
N-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C20H33N3O5S (427.2140808000001)
N-[3-(dimethylamino)propyl]-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]acetamide
C20H33N3O5S (427.2140808000001)
(2S,3S,3aR,9bR)-N-(cyclohexylmethyl)-1-(2-cyclopropyl-1-oxoethyl)-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C24H33N3O4 (427.2470938000001)
(2R,3R,3aS,9bS)-7-(4-fluorophenyl)-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-1-(1-oxopropyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C23H26FN3O4 (427.19072480000005)
3-[(3aS,4R,9bS)-1-[(2-fluorophenyl)-oxomethyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile
3-[(3aS,4S,9bS)-1-[(2-fluorophenyl)-oxomethyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile
[(1S)-7-methoxy-1-(3-methylphenyl)sulfonyl-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C22H25N3O4S (427.15656900000005)
1-[(1S)-2-acetyl-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-1-butanone
C24H33N3O4 (427.2470938000001)
(6R,7S,8S)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-4-[oxo(pyridin-4-yl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8S)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-4-[oxo(pyridin-4-yl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
N-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide
C20H33N3O5S (427.2140808000001)
N-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide
C20H33N3O5S (427.2140808000001)
N-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide
C20H33N3O5S (427.2140808000001)
N-[(E)-[4-(2-hydroxyethoxy)phenyl]methylideneamino]-N-(2-hydroxyphenyl)octanediamide
C23H29N3O5 (427.21071040000004)
N-[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide
C20H33N3O5S (427.2140808000001)
N-[[(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide
C20H33N3O5S (427.2140808000001)
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide
C22H29N5O4 (427.22194340000004)
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide
C22H29N5O4 (427.22194340000004)
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide
C22H29N5O4 (427.22194340000004)
N-[(4S,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C20H33N3O5S (427.2140808000001)
N-[(4R,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C20H33N3O5S (427.2140808000001)
N-[(4R,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C20H33N3O5S (427.2140808000001)
N-[(4R,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C20H33N3O5S (427.2140808000001)
N-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C20H33N3O5S (427.2140808000001)
N-[3-(dimethylamino)propyl]-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]acetamide
C20H33N3O5S (427.2140808000001)
N-[3-(dimethylamino)propyl]-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]acetamide
C20H33N3O5S (427.2140808000001)
N-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]acetamide
C20H33N3O5S (427.2140808000001)
N-[3-(dimethylamino)propyl]-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]acetamide
C20H33N3O5S (427.2140808000001)
3-fluoro-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide
C19H26FN3O5S (427.1577118000001)
3-fluoro-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide
C19H26FN3O5S (427.1577118000001)
3-fluoro-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide
C19H26FN3O5S (427.1577118000001)
2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[[(3-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide
2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[[(3-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide
(2S,3S,3aR,9bR)-7-(4-fluorophenyl)-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-1-(1-oxopropyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C23H26FN3O4 (427.19072480000005)
3-[(3aR,4S,9bR)-1-[(2-fluorophenyl)-oxomethyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile
3-[(3aR,4R,9bR)-1-[(2-fluorophenyl)-oxomethyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile
N,N-dimethyl-3-[4-[(1S,5R)-3-[oxo(2-pyrazinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzamide
1-[(1R)-2-acetyl-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-1-butanone
C24H33N3O4 (427.2470938000001)
(6S,7S,8S)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-4-[oxo(pyridin-4-yl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8S)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-4-[oxo(pyridin-4-yl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8R)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-4-[oxo(pyridin-4-yl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8R)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-4-[oxo(pyridin-4-yl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
14-(Methoxycarbonyl)-4,4,8alpha,12,16-pentamethyl-3,17-dioxo-5beta,9beta,10alpha,13alpha-androsta-11,15-dien-15-olate
(1R,9S,10S,11S)-12-acetyl-N-(cyclohexylmethyl)-10-(hydroxymethyl)-6-oxo-5-[(Z)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C24H33N3O4 (427.2470938000001)
(1S,9R,10R,11R)-12-acetyl-N-(cyclohexylmethyl)-10-(hydroxymethyl)-6-oxo-5-[(Z)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C24H33N3O4 (427.2470938000001)
[(4R,7S,8R)-7-[(Z)-2-methylbut-2-enoyl]oxy-4-oxido-5,6,7,8-tetrahydro-3H-pyrrolizin-4-ium-1-yl]methyl (2R)-2,3-dihydroxy-2-[(1S)-1-methoxyethyl]-3-methylbutanoate
C21H33NO8 (427.22060580000004)
2-Amino-3-[hydroxy-(2-hydroxy-3-undecanoyloxypropoxy)phosphoryl]oxypropanoic acid
2-Amino-3-[(3-butanoyloxy-2-hexanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[2,3-di(pentanoyloxy)propoxy-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(2-heptanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
3-[(3-Acetyloxy-2-octanoyloxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid
MORICIZINE
C22H25N3O4S (427.15656900000005)
D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Mozavaptan
C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2180 - Vasopressin Antagonist D045283 - Natriuretic Agents > D065092 - Antidiuretic Hormone Receptor Antagonists D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents
andrastin D(1-)
An enolate anion resulting from the deprotonation of the enol of andrastin D.Major species at pH 7.3. Published in http://dx.doi.org/10.1016/j.tet.2013.07.029
(1r,2s,4r,5s,8r,9e,11z,13e,15s,22s,23s,24s)-2,4,18-trihydroxy-9,15-dimethyl-25-oxa-17-azatetracyclo[20.2.1.0⁵,²⁴.0⁸,²³]pentacosa-6,9,11,13,17-pentaen-20-one
C25H33NO5 (427.23586080000007)
(3s,4s,6e)-7-[(1s,3as,4s,5s,7as)-1-benzyl-3,3a,5-trihydroxy-6,7-dimethyl-1,4,5,7a-tetrahydroisoindol-4-yl]-3-hydroxy-4-methylhept-6-en-2-one
C25H33NO5 (427.23586080000007)
3',4'-dihydroxy-6-methoxy-6'-(2-methylprop-1-en-1-yl)-1h-1',7'-diazaspiro[indole-2,5'-tricyclo[7.3.0.0³,⁷]dodecane]-2',3,8'-trione
(2e)-n-[(2r,3s,4as,8r,8ar)-8-chloro-2,4a-dihydroxy-8a-methyl-5-oxo-2,3,4,8-tetrahydro-1-benzopyran-3-yl]dodec-2-enimidic acid
C22H34ClNO5 (427.2125384000001)
(1s,2s,4s,4as,11ar,13as)-4-hydroxy-2-methyl-12-oxo-dodecahydroindeno[3a,3-i]indolizin-1-yl 2-(4-methoxyphenyl)acetate
C25H33NO5 (427.23586080000007)
2-({16-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-15-yl}oxy)-6-methyloxane-3,4,5-triol
C24H29NO6 (427.19947740000003)
(3r,4s,6e)-7-[(1s,3as,4s,5s,7as)-1-benzyl-3,3a,5-trihydroxy-6,7-dimethyl-1,4,5,7a-tetrahydroisoindol-4-yl]-3-hydroxy-4-methylhept-6-en-2-one
C25H33NO5 (427.23586080000007)
methyl (1s,5s,6r,9s,10s,16r,17r,20r)-9-[(acetyloxy)methyl]-20-hydroxy-5-methyl-3-azahexacyclo[11.5.1.1⁶,¹⁰.0¹,⁹.0²,⁶.0¹⁶,¹⁹]icosa-2,13(19)-diene-17-carboxylate
C25H33NO5 (427.23586080000007)
5-[5-(2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl)-4,6-dihydroxypyridin-3-yl]-5-hydroxy-7-oxabicyclo[4.1.0]heptan-2-one
C24H29NO6 (427.19947740000003)
7-(1-benzyl-3,3a,5-trihydroxy-7-methyl-6-methylidene-4,5,7,7a-tetrahydro-1h-isoindol-4-yl)-2-hydroxy-4-methylhept-6-en-3-one
C25H33NO5 (427.23586080000007)
[5-(5-ethylidene-2,4-dihydroxypyrrole-3-carbonyl)-5,7-dimethyl-6-(prop-1-en-1-yl)-2,3,4,4a,6,8a-hexahydro-1h-naphthalen-2-yl]methyl acetate
C25H33NO5 (427.23586080000007)
7-{5-benzyl-2a,3-dihydroxy-6,6a-dimethyl-1ah,2h,5h,5ah,6h-oxireno[2,3-f]isoindol-2-yl}-2-hydroxy-4-methylhept-6-en-3-one
C25H33NO5 (427.23586080000007)
methyl (1r,2r,3r,5r,6s,10s,16r,17r)-2-[(acetyloxy)methyl]-6-methyl-20-oxo-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-17-carboxylate
C25H33NO5 (427.23586080000007)
7-(1-benzyl-3,3a,5-trihydroxy-6,7-dimethyl-1,4,5,7a-tetrahydroisoindol-4-yl)-2-hydroxy-4-methylhept-6-en-3-one
C25H33NO5 (427.23586080000007)
(2-{[(2r)-3-[(8-carboxyoctanoyl)oxy]-2-hydroxypropyl phosphonato]oxy}ethyl)trimethylazanium
3-hydroxy-3-[(1r)-1-{6-hydroxy-5-[(methylsulfanyl)methyl]-3-(2-oxocyclopent-3-en-1-ylidene)-4,5-dihydro-2h-pyrazin-2-yl}ethyl]-1-methylindol-2-one
C22H25N3O4S (427.15656900000005)
(2s,4s,6e)-7-[(1s,3as,4s,5s,7as)-1-benzyl-3,3a,5-trihydroxy-6,7-dimethyl-1,4,5,7a-tetrahydroisoindol-4-yl]-2-hydroxy-4-methylhept-6-en-3-one
C25H33NO5 (427.23586080000007)
(2-{[(2r)-2-[(8-carboxyoctanoyl)oxy]-3-hydroxypropyl phosphonato]oxy}ethyl)trimethylazanium
(2s)-2-({[(3r,3ar,4s,6ar,8s,9ar,9bs)-4,8-dihydroxy-6,9-dimethylidene-2-oxo-octahydro-3h-azuleno[4,5-b]furan-3-yl]methyl}amino)-3-phenylpropanoic acid
C24H29NO6 (427.19947740000003)
(2s,4s,6e)-7-[(1s,3as,4s,5s,7s,7as)-1-benzyl-3,3a,5-trihydroxy-7-methyl-6-methylidene-4,5,7,7a-tetrahydro-1h-isoindol-4-yl]-2-hydroxy-4-methylhept-6-en-3-one
C25H33NO5 (427.23586080000007)
2,3',4'-trihydroxy-6-methoxy-6'-(2-methylprop-1-en-1-yl)-1',7'-diazaspiro[indole-3,5'-tricyclo[7.3.0.0³,⁷]dodecane]-2',8'-dione
(3s,6s)-3-({5-[(2s)-2,3-dihydroxy-3-methylbutyl]-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl}methyl)-6-methyl-3,6-dihydropyrazine-2,5-diol
C24H33N3O4 (427.2470938000001)
(2s,4s,6e)-7-[(1s,3ar,4r,5s,7as)-1-benzyl-3,3a,5-trihydroxy-6,7-dimethyl-1,4,5,7a-tetrahydroisoindol-4-yl]-2-hydroxy-4-methylhept-6-en-3-one
C25H33NO5 (427.23586080000007)
(1s,10s,12s,13e,18r)-18-[(acetyloxy)methyl]-13-ethylidene-10-hydroxy-18-(methoxycarbonyl)-15-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-trien-15-ium
(1s,13r,14s,17s,19r)-7,10-dihydroxy-1,14,18,18-tetramethyl-2-oxa-6-azapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3(11),4(8),6,9-tetraen-17-yl acetate
C25H33NO5 (427.23586080000007)
(2s,4s,6e)-7-[(1as,2r,2as,5s,5as,6s,6ar)-5-benzyl-2a,3-dihydroxy-6,6a-dimethyl-1ah,2h,5h,5ah,6h-oxireno[2,3-f]isoindol-2-yl]-2-hydroxy-4-methylhept-6-en-3-one
C25H33NO5 (427.23586080000007)
(10s,11r,14s,15r,16s)-14-hydroxy-4-(2-hydroxyethyl)-10,14-dimethyl-10-(4-methylpent-3-en-1-yl)-9,18-dioxa-4-azapentacyclo[13.2.1.0²,⁶.0⁸,¹⁷.0¹¹,¹⁶]octadeca-1(17),2(6),7-trien-5-one
C25H33NO5 (427.23586080000007)
(1s,2s,4r,4as,11ar,13as)-4-hydroxy-2-methyl-12-oxo-dodecahydroindeno[3a,3-i]indolizin-1-yl 2-(4-methoxyphenyl)acetate
C25H33NO5 (427.23586080000007)
n-[2-(4-{[(2e)-4,6,7-trihydroxy-3,7-dimethyloct-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid
C25H33NO5 (427.23586080000007)
(1s,13r,14s,17s,19s)-7,10-dihydroxy-13,14,18,18-tetramethyl-2-oxa-6-azapentacyclo[11.8.0.0¹,¹⁷.0³,¹¹.0⁴,⁸]henicosa-3(11),4(8),6,9-tetraen-19-yl acetate
C25H33NO5 (427.23586080000007)
(2s,4s,6e)-7-[(1s,3as,4r,5s,7as)-1-benzyl-3,3a,5-trihydroxy-6,7-dimethyl-1,4,5,7a-tetrahydroisoindol-4-yl]-2-hydroxy-4-methylhept-6-en-3-one
C25H33NO5 (427.23586080000007)
n-[2-(4-{[(2e,4r,6s)-4,6,7-trihydroxy-3,7-dimethyloct-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid
C25H33NO5 (427.23586080000007)
(2s)-2-{[(2s,3r)-2-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-1,3-dihydroxybutylidene]amino}-5-(n-hydroxyacetamido)pentanoic acid
C18H25N3O9 (427.15907200000004)
n-[2-(4-{[(4r,6s)-4,6,7-trihydroxy-3,7-dimethyloct-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid
C25H33NO5 (427.23586080000007)
7-hydroxy-2-(2-hydroxyethyl)-6-(3-methylbut-2-en-1-yl)-3-oxo-1h-isoindol-5-yl 2,4-dihydroxy-6-methylbenzoate
(6s,7r,8r)-6-hydroxy-6',7'-dimethoxy-2'-methyl-3',4',6,8-tetrahydro-2h-spiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinolin]-8-yl acetate
7,10-dihydroxy-13,14,18,18-tetramethyl-2-oxa-6-azapentacyclo[11.8.0.0¹,¹⁷.0³,¹¹.0⁴,⁸]henicosa-3(11),4(8),6,9-tetraen-19-yl acetate
C25H33NO5 (427.23586080000007)
7,10-dihydroxy-1,14,18,18-tetramethyl-2-oxa-6-azapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3,6,8,10-tetraen-17-yl acetate
C25H33NO5 (427.23586080000007)
10,16-dihydroxy-5-methyl-12-methylidene-3-oxo-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-19-yl 2-methylbutanoate
C25H33NO5 (427.23586080000007)
7-(1-benzyl-3,3a,5-trihydroxy-6,7-dimethyl-1,4,5,7a-tetrahydroisoindol-4-yl)-3-hydroxy-4-methylhept-6-en-2-one
C25H33NO5 (427.23586080000007)
(1s,17s,18s,19s)-17-(butanoyloxy)-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,15-tetraen-18-yl butanoate
C24H29NO6 (427.19947740000003)
methyl 2-[(acetyloxy)methyl]-6-methyl-20-oxo-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-17-carboxylate
C25H33NO5 (427.23586080000007)
n-[(2r,3s,4as,8r,8ar)-8-chloro-2,4a-dihydroxy-8a-methyl-5-oxo-2,3,4,8-tetrahydro-1-benzopyran-3-yl]dodec-2-enimidic acid
C22H34ClNO5 (427.2125384000001)
(2s,3'r,4's,6's,9's)-3',4'-dihydroxy-6-methoxy-6'-(2-methylprop-1-en-1-yl)-1h-1',7'-diazaspiro[indole-2,5'-tricyclo[7.3.0.0³,⁷]dodecane]-2',3,8'-trione
(2s,4s,6e)-7-[(1s,3ar,4r,5s,7s,7as)-1-benzyl-3,3a,5-trihydroxy-7-methyl-6-methylidene-4,5,7,7a-tetrahydro-1h-isoindol-4-yl]-2-hydroxy-4-methylhept-6-en-3-one
C25H33NO5 (427.23586080000007)
6-hydroxy-6',7'-dimethoxy-2'-methyl-3',4',6,8-tetrahydro-2h-spiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinolin]-8-yl acetate
5-{5-[(1s,2s,4ar,6s,8as)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4,6-dihydroxypyridin-3-yl}-5-hydroxy-7-oxabicyclo[4.1.0]heptan-2-one
C24H29NO6 (427.19947740000003)
(3s,3'r,4's,6's,9's)-2,3',4'-trihydroxy-6-methoxy-6'-(2-methylprop-1-en-1-yl)-1',7'-diazaspiro[indole-3,5'-tricyclo[7.3.0.0³,⁷]dodecane]-2',8'-dione
(1r,2s,4r,5s,8r,9e,11z,13e,22s,23s,24s)-2,4,18-trihydroxy-9,15-dimethyl-25-oxa-17-azatetracyclo[20.2.1.0⁵,²⁴.0⁸,²³]pentacosa-6,9,11,13,17-pentaen-20-one
C25H33NO5 (427.23586080000007)
(2s,3r,4r,5r,6s)-2-{[(9r)-16-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-15-yl]oxy}-6-methyloxane-3,4,5-triol
C24H29NO6 (427.19947740000003)
(2s)-2-({[(3r,3ar,4s,6ar,8s,9ar,9br)-4,8-dihydroxy-6,9-dimethylidene-2-oxo-octahydro-3h-azuleno[4,5-b]furan-3-yl]methyl}amino)-3-phenylpropanoic acid
C24H29NO6 (427.19947740000003)
7-{5-benzyl-2a,3-dihydroxy-6,6a-dimethyl-1ah,2h,5h,5ah,6h-oxireno[2,3-f]isoindol-2-yl}-3-hydroxy-4-methylhept-6-en-2-one
C25H33NO5 (427.23586080000007)
(13e)-2,4,18-trihydroxy-9,15-dimethyl-25-oxa-17-azatetracyclo[20.2.1.0⁵,²⁴.0⁸,²³]pentacosa-6,9,11,13,17-pentaen-20-one
C25H33NO5 (427.23586080000007)
(3r,4s,6e)-7-[(1as,2s,2as,5s,5as,6s,6ar)-5-benzyl-2a,3-dihydroxy-6,6a-dimethyl-1ah,2h,5h,5ah,6h-oxireno[2,3-f]isoindol-2-yl]-3-hydroxy-4-methylhept-6-en-2-one
C25H33NO5 (427.23586080000007)
3-{[5-(2,3-dihydroxy-3-methylbutyl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-6-methyl-3,6-dihydropyrazine-2,5-diol
C24H33N3O4 (427.2470938000001)
4-hydroxy-2-methyl-12-oxo-dodecahydroindeno[3a,3-i]indolizin-1-yl 2-(4-methoxyphenyl)acetate
C25H33NO5 (427.23586080000007)
(2s,4s,6e)-7-[(1as,2s,2as,5s,5as,6s,6ar)-5-benzyl-2a,3-dihydroxy-6,6a-dimethyl-1ah,2h,5h,5ah,6h-oxireno[2,3-f]isoindol-2-yl]-2-hydroxy-4-methylhept-6-en-3-one
C25H33NO5 (427.23586080000007)
[(2s,4ar,5s,6r,8as)-5-[(5z)-5-ethylidene-2,4-dihydroxypyrrole-3-carbonyl]-5,7-dimethyl-6-[(1e)-prop-1-en-1-yl]-2,3,4,4a,6,8a-hexahydro-1h-naphthalen-2-yl]methyl acetate
C25H33NO5 (427.23586080000007)